These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7585923)

  • 1. Neurogenic model of migraine.
    Buzzi MG; Bonamini M; Moskowitz MA
    Cephalalgia; 1995; 15(4):277-80. PubMed ID: 7585923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The trigemino-vascular system and migraine.
    Buzzi MG; Moskowitz MA
    Pathol Biol (Paris); 1992 Apr; 40(4):313-7. PubMed ID: 1379707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model.
    Bolay H; Reuter U; Dunn AK; Huang Z; Boas DA; Moskowitz MA
    Nat Med; 2002 Feb; 8(2):136-42. PubMed ID: 11821897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pearls and pitfalls in experimental in vivo models of migraine: dural trigeminovascular nociception.
    Akerman S; Holland PR; Hoffmann J
    Cephalalgia; 2013 Jun; 33(8):577-92. PubMed ID: 23671254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma protein extravasation induced in the rat dura mater by stimulation of the parasympathetic sphenopalatine ganglion.
    Delépine L; Aubineau P
    Exp Neurol; 1997 Oct; 147(2):389-400. PubMed ID: 9344563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental migraine models and their relevance in migraine therapy.
    Arulmani U; Gupta S; VanDenBrink AM; Centurión D; Villalón CM; Saxena PR
    Cephalalgia; 2006 Jun; 26(6):642-59. PubMed ID: 16686903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurogenic inflammation in the context of migraine.
    Williamson DJ; Hargreaves RJ
    Microsc Res Tech; 2001 May; 53(3):167-78. PubMed ID: 11301492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral and central activation of trigeminal pain pathways in migraine: data from experimental animal models.
    Buzzi MG; Tassorelli C; Nappi G
    Cephalalgia; 2003; 23 Suppl 1():1-4. PubMed ID: 12699454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into the pharmacological targeting of the trigeminocervical complex in the context of treatments of migraine.
    Akerman S; Romero-Reyes M
    Expert Rev Neurother; 2013 Sep; 13(9):1041-59. PubMed ID: 23952299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of calcitonin gene-related peptide release after superior sagittal sinus stimulation in cat: a comparison of avitriptan and CP122,288.
    Knight YE; Edvinsson L; Goadsby PJ
    Neuropeptides; 1999 Feb; 33(1):41-6. PubMed ID: 10657470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive validity of endpoints used in electrophysiological modelling of migraine in the trigeminovascular system.
    Farkas B; Kardos P; Orosz S; Tarnawa I; Csekő C; Lévay G; Farkas S; Lendvai B; Kovács P
    Brain Res; 2015 Nov; 1625():287-300. PubMed ID: 26358146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cortical spreading depression on basal and evoked traffic in the trigeminovascular sensory system.
    Lambert GA; Truong L; Zagami AS
    Cephalalgia; 2011 Oct; 31(14):1439-51. PubMed ID: 21940490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the trigeminovascular system by mechanical distension of the superior sagittal sinus in the cat.
    Kaube H; Hoskin KL; Goadsby PJ
    Cephalalgia; 1992 Jun; 12(3):133-6. PubMed ID: 1623506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trigeminal pain pathway: peripheral and central activation as experimental models of migraine.
    Buzzi MG
    Funct Neurol; 2001; 16(4 Suppl):77-81. PubMed ID: 11996534
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence for 5-HT1B/1D receptors mediating the antimigraine effect of sumatriptan and dihydroergotamine.
    Buzzi MG; Moskowitz MA
    Cephalalgia; 1991 Sep; 11(4):165-8. PubMed ID: 1660351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional immunohistochemistry of neuropeptides and nitric oxide synthase in the nerve fibers of the supratentorial dura mater in an experimental migraine model.
    Knyihár-Csillik E; Tajti J; Chadaide Z; Csillik B; Vécsei L
    Microsc Res Tech; 2001 May; 53(3):193-211. PubMed ID: 11301495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception.
    Holland PR; Akerman S; Goadsby PJ
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1380-5. PubMed ID: 16160082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurovascular and molecular mechanisms in migraine headaches.
    Moskowitz MA; Macfarlane R
    Cerebrovasc Brain Metab Rev; 1993; 5(3):159-77. PubMed ID: 8217498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional imaging of the trigeminal system: applications to migraine pathophysiology.
    Borsook D; Burstein R; Moulton E; Becerra L
    Headache; 2006 Jun; 46 Suppl 1():S32-8. PubMed ID: 16927962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basic mechanisms in vascular headache.
    Moskowitz MA
    Neurol Clin; 1990 Nov; 8(4):801-15. PubMed ID: 2175382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.